Clinical Trial Update: Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/2 study evaluating primary chemotherapy in patients with HER2-positive early breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Prof Dirk Elling | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED